Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1980 4
1981 2
1982 2
1983 1
1984 2
1985 5
1986 4
1987 8
1988 16
1989 17
1990 24
1991 25
1992 24
1993 36
1994 23
1995 99
1996 34
1997 47
1998 42
1999 52
2000 57
2001 55
2002 52
2003 59
2004 67
2005 60
2006 87
2007 119
2008 101
2009 112
2010 119
2011 139
2012 170
2013 202
2014 220
2015 195
2016 175
2017 182
2018 187
2019 243
2020 218
2021 238
2022 200
2023 189
2024 82

Text availability

Article attribute

Article type

Publication date

Search Results

3,630 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 69"
Page 1
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.
OBJECTIVE: To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). METHODS: Patients with moderate-to-severe SLE (score of 8 on the Safety of Estrogens in Lupus Erythematosus National Assessment [SELENA] version …
OBJECTIVE: To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). METHODS: Pa …
Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.
Banday AZ, Nisar R, Patra PK, Kaur A, Sadanand R, Chaudhry C, Bukhari STA, Banday SZ, Bhattarai D, Notarangelo LD. Banday AZ, et al. J Clin Immunol. 2023 Dec 22;44(1):17. doi: 10.1007/s10875-023-01633-1. J Clin Immunol. 2023. PMID: 38129705
Although numerous studies have provided a detailed description of CD40L deficiency, reports of CD40 deficiency are scarce. Herein, we describe the characteristics of all reported patients with CD40 deficiency. ...Very low to undetectable IgG levels and severe …
Although numerous studies have provided a detailed description of CD40L deficiency, reports of CD40 deficiency are scarce. Her …
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yılmaz T, Gümüş E, Barış S, Kuşkonmaz B, Ozgur TT, Bali P, Santisteban I, Orhan D, Yüce A, Cetinkaya D, Boztug K, Hershfield M, Sanal O, Tezcan İ. Cagdas D, et al. J Clin Immunol. 2018 May;38(4):484-493. doi: 10.1007/s10875-018-0496-9. Epub 2018 May 9. J Clin Immunol. 2018. PMID: 29744787
RESULTS: Ten out of 13 patients were diagnosed as SCID, while 3 out of 13 were diagnosed as delayed-/late-onset ADA deficiency. Late-onset ADA deficiency patients had clinical and laboratory findings of combined immunodeficiency (CID). ...Enzyme replacement t …
RESULTS: Ten out of 13 patients were diagnosed as SCID, while 3 out of 13 were diagnosed as delayed-/late-onset ADA deficiency. Late- …
The Disease Burden and Societal Costs of Hereditary Angioedema.
Fijen LM, Klein PCG, Cohn DM, Kanters TA. Fijen LM, et al. J Allergy Clin Immunol Pract. 2023 Aug;11(8):2468-2475.e2. doi: 10.1016/j.jaip.2023.03.032. Epub 2023 Mar 27. J Allergy Clin Immunol Pract. 2023. PMID: 36990433 Free article.
RESULTS: The response rate was 78% (69 of 88). The entire sample had a mean Angioedema Activity Score of 16.61, and 36% of participants had poorly controlled disease as expressed by the Angioedema Control Test. ...Utilities dropped by 0.320 points during an angioede …
RESULTS: The response rate was 78% (69 of 88). The entire sample had a mean Angioedema Activity Score of 16.61, and 36% of par …
Asthma as aetiology of bronchiectasis in Finland.
Mäntylä J, Mazur W, Törölä T, Bergman P, Saarinen T, Kauppi P. Mäntylä J, et al. Respir Med. 2019 Jun;152:105-111. doi: 10.1016/j.rmed.2019.04.022. Epub 2019 Apr 30. Respir Med. 2019. PMID: 31128603 Free article.
As 41% BE were idiopathic, in 11% the disorder was postinfectious and others were associated to rheumatic disease, Alpha-1-antitrypsin deficiency, IgG deficiency and Kartagener syndrome. The most common co-morbidities in addition to asthma were cardiovascular diseas …
As 41% BE were idiopathic, in 11% the disorder was postinfectious and others were associated to rheumatic disease, Alpha-1-antitrypsin de …
Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study.
Shen Q, Sheng L, Zhang J, Ye J, Zhou J. Shen Q, et al. Infection. 2022 Feb;50(1):169-178. doi: 10.1007/s15010-021-01679-6. Epub 2021 Aug 5. Infection. 2022. PMID: 34351597 Free PMC article.
PURPOSE: Talaromyces marneffei (TM) is a pathogenic fungus endemic in Southeast Asia and human immunodeficiency virus (HIV)-positive populations, but studies related to non-endemic areas and HIV-negative populations are still limited. ...There were significantly more HIV-p …
PURPOSE: Talaromyces marneffei (TM) is a pathogenic fungus endemic in Southeast Asia and human immunodeficiency virus (HIV)-positive …
The devastating effects of humeral nonunion on health-related quality of life.
Brinker MR, Loftis CM, Khoriaty JD, Dunn WR. Brinker MR, et al. J Shoulder Elbow Surg. 2022 Dec;31(12):2578-2585. doi: 10.1016/j.jse.2022.05.012. Epub 2022 Jun 16. J Shoulder Elbow Surg. 2022. PMID: 35718254 Review.
At initial clinical evaluation, all patients were asked to complete the 12-Item Short Form Health Survey (SF-12), Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, Brief Pain Inventory (BPI), and a time trade-off questionnaire. These scores were compared to …
At initial clinical evaluation, all patients were asked to complete the 12-Item Short Form Health Survey (SF-12), Disabilities of the Arm, S …
Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency.
Sperlich JM, Grimbacher B, Workman S, Haque T, Seneviratne SL, Burns SO, Reiser V, Vach W, Hurst JR, Lowe DM. Sperlich JM, et al. J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):159-168.e3. doi: 10.1016/j.jaip.2017.05.024. Epub 2017 Jul 19. J Allergy Clin Immunol Pract. 2018. PMID: 28734862 Free PMC article.
BACKGROUND: Patients with common variable immunodeficiency (CVID) suffer frequent respiratory tract infections despite immunoglobulin replacement and are prescribed significant quantities of antibiotics. ...OBJECTIVES: To describe the nature, frequency, treatment, and clin …
BACKGROUND: Patients with common variable immunodeficiency (CVID) suffer frequent respiratory tract infections despite immunoglobulin …
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects.
Raynaud C, Roche N, Chouaid C. Raynaud C, et al. Respir Res. 2011 Sep 1;12(1):117. doi: 10.1186/1465-9921-12-117. Respir Res. 2011. PMID: 21884608 Free PMC article. Review.
INTRODUCTION: An association between HIV infection and chronic obstructive pulmonary disease (COPD) has been observed in several studies. OBJECTIVE AND METHODS: we conducted a review of the literature linking HIV infection to COPD, focusing on clinical and epidemiological …
INTRODUCTION: An association between HIV infection and chronic obstructive pulmonary disease (COPD) has been observed in several stud …
Respiratory Comorbidities Associated with Bronchiectasis in Patients with Common Variable Immunodeficiency in the USIDNET Registry.
Correa-Jimenez O, Restrepo-Gualteros S, Nino G, Cunningham-Rundles C, Sullivan KE, Fuleihan RL, Gutierrez MJ. Correa-Jimenez O, et al. J Clin Immunol. 2023 Nov;43(8):2208-2220. doi: 10.1007/s10875-023-01593-6. Epub 2023 Nov 7. J Clin Immunol. 2023. PMID: 37932514
BACKGROUND: Bronchiectasis is a major respiratory complication in patients with common variable immunodeficiency (CVID) and is associated with recurrent pulmonary infections. ...Further study into predisposing conditions related to the development of bronchiectasis in CVID …
BACKGROUND: Bronchiectasis is a major respiratory complication in patients with common variable immunodeficiency (CVID) and is associ …
3,630 results